{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:59:21Z","timestamp":1775055561787,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.08.026","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T18:16:00Z","timestamp":1220811360000},"page":"5684-5688","source":"Crossref","is-referenced-by-count":16,"title":["Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Fasanella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Garofolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carattoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Adone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.08.026_bib1","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/IAI.73.7.4043-4053.2005","article-title":"Oral spore vaccine based on live attenuated nontoxigenic Bacillus anthracis expressing recombinant mutant protective antigen","volume":"73","author":"Aloni-Grinstein","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.08.026_bib2","first-page":"209","article-title":"Persistence of antibodies to Mycoplasma agalactiae in vaccinated sheep","volume":"21","author":"Buonavoglia","year":"1998","journal-title":"New Microbiol."},{"key":"10.1016\/j.vaccine.2008.08.026_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/JCM.41.3.1212-1218.2003","article-title":"Bacillus anthracis virulence in guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality","volume":"41","author":"Coker","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib5","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib6","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1016\/S0264-410X(01)00159-1","article-title":"Detection of anthrax vaccine virulence factors by Polymerase Chain Reaction","volume":"19","author":"Fasanella","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib7","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/JCM.43.7.3398-3401.2005","article-title":"Molecular diversity among Bacillus anthracis isolates in Italy","volume":"43","author":"Fasanella","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib8","unstructured":"Fasanella A, Fabiano MP, Garofolo G, Losito S. Preliminary studies on recombinant protective antigen (rPA) vaccine against anthrax for veterinary use. In: Abstract of the international veterinary vaccines and diagnostic conference, Oslo, Norway, June 25\u201329, 2006. p. 69."},{"key":"10.1016\/j.vaccine.2008.08.026_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","article-title":"Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice","volume":"167","author":"Firoved","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib10","first-page":"33","article-title":"Anthrax vaccines","volume":"271","author":"Friedlander","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax","volume":"20","author":"Gaur","year":"2002","journal-title":"Toxin Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib12","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib13","unstructured":"Guidelines for the Surveillance and Control of Anthrax in Human and Animals (1998). WHO\/EMC\/ZDI\/98.6."},{"key":"10.1016\/j.vaccine.2008.08.026_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","article-title":"Anthrax: the disease in relation to vaccines","volume":"2","author":"Hambleton","year":"1984","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib15","unstructured":"Joellenbeck L, Zwanziger L, Durch J, Strom B, editors. Is it safe? Does it work? In: The anthrax vaccine. Washington, DC: National Academy Press; 2002."},{"key":"10.1016\/j.vaccine.2008.08.026_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0076-6879(88)65019-1","article-title":"Production and purification of anthrax toxin","volume":"165","author":"Leppla","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib18","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine","volume":"24","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib19","unstructured":"Office International des Epizooties. Manual of diagnostic tests and vaccines for terrestrial animals, 5th ed. Paris, France: Office International des Epizooties; 2004."},{"key":"10.1016\/j.vaccine.2008.08.026_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib21","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.vaccine.2005.08.065","article-title":"Evidence for adjuvanticity of anthrax edema toxin","volume":"24","author":"Quesnel-Hellmann","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.026_bib23","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.026_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0966-842X(00)01755-8","article-title":"Discovery of the anthrax toxin: the beginning of in vivo studies on pathogenic bacteria","volume":"8","author":"Smith","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jcp.56.3.182","article-title":"Bacillus anthracis","volume":"56","author":"Spencer","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2008.08.026_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbrc.2003.11.134","article-title":"Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis","volume":"313","author":"Tonello","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2008.08.026_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2672.1999.00894.x","article-title":"Experiences with vaccination and epidemiological investigations on an anthrax outbreak in Australia in 1997","volume":"87","author":"Turner","year":"1997","journal-title":"J Appl Microbiol"},{"issue":"pt 6","key":"10.1016\/j.vaccine.2008.08.026_bib28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T03:55:41Z","timestamp":1545796541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08011298"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}